GSK3B and Alzheimer disease: In this study, AD-related Aβ1–42 peptides evoked a significant but transient decrease in the total Gsk-3β protein level after 24 h, with no changes after 96 h, and with no significant changes in the level of the (inactive) form phosphorylated on serine 9.